Structural Biology in Cancer Research

One of the major areas of attentiveness is cancer research. Cancer is defined as the abnormal growth of cells. There are numerous types of cancer that affects people of all age. Structural biology combines with molecular biology in order to design novel drugs mainly to cure cancer. The biologists accomplish research in order to understand the macromolecules, identify different drug targets and improvise cancer remedy. The major part of research is being carried out in the area of cancer. The main aim is to design and discover novel and effective drugs to cure the disease. Basic biology combined with molecular modelling mainly aims at drug medication planning. Eventually, many researchers in Structural biology carry out cancer research to broaden the exploitation of molecular understanding of biomolecules in the advancement of novel cancer therapies. Cancer immunotherapy is also used as the response of immune system to decline level of cancer. Immunotherapies can be a better way of treating cancer. The malignant tumour cells are attacked by stimulating the immune system as these cells are responsible to exploit the fact that cancer cells often have molecules on their surface that can be detected by the tumour-associated antigens

 

  • Cancer Systems Biology
  • Tumorigenesis
  • Cancer Heterogeneity
  • Epidemiology
  • Statistical and Mechanistic Modelling of Signalling Networks

Related Conference of Structural Biology in Cancer Research

May 10-11, 2019

8th Asia Pacific Glycobiology Congress

Tokyo, Japan
July 11-12, 2019

8th Glycobiology World Congress

Zurich, Switzerland
May 10-11, 2019

4th International Conference on Enzymology & Molecular Biology

| Radisson Hotel Narita | Tokyo, Japan
October 07-08, 2019

4th International Conference on Molecular Biology & Nucleic Acids

Chicago, Illinois, USA

Structural Biology in Cancer Research Conference Speakers

Recommended Sessions

Related Journals

Are you interested in